Skip to main content
SpringerLink
Log in

Sequential methotrexate/5-FU: FdUMP formation and TS inhibition in a transplantable rodent colon adenocarcinoma

  • Original Articles
  • 5-Fluorouracil, Methotrexate, Thymidylate synthetase
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Summary

Parameters for inhibition of thymidylate synthetase were studied after sequential methotrexate/5-fluorouracil (5-FU) administration in a dimethylhydrazine (DMH)-induced transplantable rat colon carcinoma. Tumor-bearing rats were treated with methotrexate (MTX) 40 mg/kg IP Bolus 5-FU, 100 mg/kg IP, was injected after 24 h. Micromethods for assay of 5-fluoro-2′-deoxyuridylate (FdUMP) and thymidylate synthetase (TS) were used to study the in vivo intracellular pharmacokinetics of 5-FU.

Formation of FdUMP was equally rapid in tumors regardless of MTX pretreatment, with peak values found at 30 min. Although MTX pretreatment did not increase peak FdUMP levels, it appeared to result in increased persistence of FdUMP, well in excess of available TS-binding sites, at 24 and 48 h. The combination therapy was less effective in terms of TS inhibition over the first 8 h after 5-FU administration, but may have been associated with improved TS inhibition at later time points.

Total levels of TS (TStot) steadily increased from a pre-5-FU treatment level of 18.8 pmol to more than 40 pmol/g at 24 h. MTX per se had no apparent effect on baseline TStot levels or on the 5-FU-mediated increases in TStot.

We conclude that MTX and 5-FU were antagonistic in terms of TS inhibition over the first 8 h after 5-FU in this DMH-induced rat colon carcinoma, but were possibly synergistic in increasing persistent levels of FdUMP and TS inhibition at later time points. The observation that 5-FU treatment can result in progressive increases in TS levels in some tumors suggests that this may be an important mechanism of 5-FU resistance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

5-FU:

5-fluorouracil

CH2FH4 :

5,10-methylenepteroylmonoglutamatic acid

FdUMP:

5-fluoro-2-deoxyuridylate

TS:

thymidylate synthetase

TSf :

free, non FdUMP-bound TS

TSb :

ternary complex bound TS enzyme

TStot :

TSf+TSb

MTX:

methotrexate

References

  1. Allegra CJ (1983) Methotrexate and fluorouracil following tamoxifen and premarin in advanced breast cancer. Semin Oncol 10 (2) [Suppl 2]

  2. Ardalan B, Buscaglia MD, Schein PS (1978) Tumour 5-fluorodeoxyuridylate concentration as a determinant of 5-fluorouracil response. Biochem Pharmacol 27: 1

    Google Scholar 

  3. Baskin F, Carrlin SC, Krau P, Friedkin M, Rosenberg RN (1975) Experimental chemotherapy of neuroblastoma. II. Increased thymidylate synthetase activity in a 5-fluoro-deoxyuridine-resistant variant of mouse neuroblastoma. Mol Pharmacol 11: 105

    Google Scholar 

  4. Bertino JR, Mini E, Fernandes DJ (1983) Sequential methotrexate and 5-fluorouracil: Mechanisms of synergy. Semin Oncol 10 (2) [Suppl 2]

  5. Bonney RJ, Maley F (1978) Effect of methotrexate on thymidylate synthetase in cultured parenchymal cells isolated from regenerating rat liver. Cancer Res 35: 1950

    Google Scholar 

  6. Browman GP, Archibald SD, Young JEM, Hryniuk WM, Russel R, Kiehl K, Levine MN (1983) Prospective randomized trial of one-hour sequential versus simultaneous methotrexate plus 5-fluorouracil in advanced and recurrent squamous cell head and neck cancer. J Clin Oncol 12: 787

    Google Scholar 

  7. Cadman E, Heimer R, Davis L (1979) Enhanced 5-fluorouracil nucleotide formation after methotrexate administration. Explanation for drug synergism. Science 205: 1135

    Google Scholar 

  8. Carrico CK, Glazer RJ (1979a) Augmentation by thymidine of the incorporation and distribution of 5-fluorouracil in ribosomal RNA. Biochem Biophys Res Commun 87: 664

    Google Scholar 

  9. Carrico CK, Glazer RJ (1979b) Effect of 5-fluorouracil on the synthesis and translation of polyadenylic acid-containing RNA from regenerating rat liver. Cancer Res 39: 3694

    Google Scholar 

  10. Coates AS, Tattersall MHN, Swanson C, Hedley D, Fox RM, Raghavan D, et al (1984) Combination therapy with methotrexate and 5-fluorouracil: a prospective randomized clinical trial of order of administration. J Clin Oncol 7: 756

    Google Scholar 

  11. Cory JG, Breland JC, Carter GC (1979) Effect of 5-fluorouracil on RNA metabolism in Novikoff hepatoma cells. Cancer Res 39: 4905

    Google Scholar 

  12. Danenberg PV, Lockshin A (1982) Thymidylate synthetase. Substrate complex formation. Mol Cell Biochem 43: 49

    Google Scholar 

  13. Danenberg PV, Heidelberger C, Mulkins M, Peterson AR (1981) The incorporation of 5-fluoro-2′-deoxyuridine into DNA of mammalian tumor cells. Biochem Biophys Res Commun 102: 654

    Google Scholar 

  14. Evans RM, Laskin JP, Hakala MT (1980) Assessment of growth-limiting events caused by 5-fluorouracil in mouse cells and in human cells. Cancer Res 40: 4113

    Google Scholar 

  15. Houghton JA, Houghton PJ (1980) 5-Fluorouracil in combination with hypoxanthine and allopurinol: Toxicity and metabolism in xenografts of human colonic carcinoma in mice. Biochem Pharmacol 29: 2077

    Google Scholar 

  16. Houghton JA, Houghton PJ, Wooten RS, (1979) Mechanism of induction of gastrointestinal toxicity in the mouse by 5-fluorouracil, 5-fluorouridine, and 5-fluoro-2′-deoxyuridine. Cancer Res 39: 2406

    Google Scholar 

  17. Ingraham HA, Tsen BY, Goulian M (1983) Nucleotide levels and incorporation of 5-fluorouracil and uracil into DNA of cells treates with 5-fluoroudeoxyuridine. Mol Pharmacol 21: 211

    Google Scholar 

  18. Kufe DW, Major PP (1981) Fluorouracil incorporation into human breast carcinoma RNA correlates with cytotoxicity. J Biol Chem 256: 9802

    Google Scholar 

  19. Langebach RJ, Danenberg PV, Heidelberger C (1972) Thymidylate synthetase: mechanism of inhibition by 5-fluoro-2′-deoxyuridylate. Biochem Biophys Res Commun 48: 1565

    Google Scholar 

  20. Martin D, Stolfi R, Spiegelman S (1978) Striking augmentation of the in vivo anti-cancer activity of 5-fluorouracil (FU) by combination with pyrimidine nucleotides; and RNA effect. Proc Am Assoc Cancer Res 19: 22

    Google Scholar 

  21. Moran RG, Spears CP, Heidelberger C (1979) Biochemical determinants of tumor sensitivity to 5-fluorouracil: Ultrasensitive methods for the determination of 5′-fluoro-2′-deoxyuridylate, 2′ deoxyuridylate and thymidylate synthetase. Proc Natl Acad Sci USA 76: 1456

    Google Scholar 

  22. Myers EC (1981) The pharmacology of the fluoropyrimidines. Pharmacol Rev 33: 1

    Google Scholar 

  23. Myers CE, Young RC, Johns DG, Chabner BA (1974) Assay of 5-fluorodeoxyuridine-5′-monophosphate and deoxyuridine-5′-monophosphate pools following 5-fluorouracil. Cancer Res 34: 2682

    Google Scholar 

  24. Nazar RN, Lawford HG, Wong JTF (1979) An improved procedure for extraction and analysis of cellular nucleotides. Biochemistry 35: 305

    Google Scholar 

  25. Piper AA, Nott SE, Machinnon WB, et al (1983) Critical modulation by thymidine and hypoxanthine of sequential methotrexate-5-fluorouracil synergism in murine L1210 cells. Cancer Res 43: 5701

    Google Scholar 

  26. Pittman SV, Cowall DC, Bertino RJ (1983) Methotrexate and 5-fluorouracil in sequence in squamos head and neck cancer. Semin Oncol 10 (2) [Suppl 2]: 15

    Google Scholar 

  27. Priest DG, Ledford BE, Doig MT (1980) Increased thymidylate synthetase in 5-fluoro-deoxyuridine resistant cultured haepatoma cells. Biochem Pharmacol 29: 1549

    Google Scholar 

  28. Rustum Y, Schwartz H (1973) Methods for the separation and identification of ribonucleotides on DEAE cellulose. Anal Biochem 53: 411

    Google Scholar 

  29. Santi DV, McHenry CS (1972) 5′-fluoro-2′ deoxyuridylate: covalent complex with thymidylate synthetase. Proc Natl Acad Sci USA 69: 1855

    Google Scholar 

  30. Spears CP (1984) Thymidylate synthetase inhibition in Peyton adenocarcinoma xenografts following bolus 5-fluorouracil. Excerpta Medica (in press)

  31. Spears CP, Shahinian AH, Moran RG, Heidelberger C, Corbett TH (1982) In vivo kinetics of thymidylate synthetase inhibition in 5-fluorouracil-sensitive and-resistant murin colon adenocarcinomas. Cancer Res 42: 450

    Google Scholar 

  32. Spears CP, Gustavsson B, Spicer D, Mitchell MS, Berne M, Danenberg PV (1983) Thymidylate synthetase inhibition in malignant tumors and normal liver of patients given intravenous 5-fluorouracil. Cancer Res 44: 4144

    Google Scholar 

  33. Spears CP, Shani J, Shahinian AH, Wolf W, Heidelberger C, Danenberg PV (1985) Assay and time course of incorporation of 5-fluorouracil into RNA of L1210/0 ascites cells in vivo. Mol Pharmacol 27: 302

    Google Scholar 

  34. Tanaka M, Kimura K, Yoshida S (1983) Enhancement of the incorporation of 5-fluorodeoxyuridylate into DNA of HL-60 cells by metabolic modulations. Cancer Res 43: 5145

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Östra sjukhuset, University of Gothenburg, S-41685, Gothenburg, Sweden

    Magnus H. O. Berne, Bengt G. Gustavsson & Olle Almersjö

  2. Comprehensive Cancer Center, University of Southern California, Los Angeles, Calif, USA

    Paul C. Spears & Roland Frösing

Authors
  1. Magnus H. O. Berne
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bengt G. Gustavsson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Olle Almersjö
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Paul C. Spears
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Roland Frösing
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

The work described in this paper was supported by Grant CA 27,610 from the National Cancer Institute NIH, and by funds from the Assar Gabrielsson Foundation, the Wellcome Foundation, the Swedish Cancer Society, the Swedish Medical Council, and Göteborgs Läkarsällskap

Rights and permissions

Reprints and permissions

About this article

Cite this article

Berne, M.H.O., Gustavsson, B.G., Almersjö, O. et al. Sequential methotrexate/5-FU: FdUMP formation and TS inhibition in a transplantable rodent colon adenocarcinoma. Cancer Chemother. Pharmacol. 16, 237–242 (1986). https://doi.org/10.1007/BF00293984

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00293984

Keywords

Search

Navigation